GOLDMAN SACHS GROUP INC - TALARIS THERAPEUTICS INC ownership

TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 59 filers reported holding TALARIS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TALARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$245,735
+321.0%
8,745
-54.5%
0.00%
Q2 2023$58,365
+48.2%
19,199
-8.4%
0.00%
Q1 2023$39,395
-3.2%
20,955
-47.5%
0.00%
Q4 2022$40,682
+47761.2%
39,884
+23.4%
0.00%
Q3 2022$85
-22.7%
32,314
+32.3%
0.00%
Q2 2022$110
-100.0%
24,425
-1.6%
0.00%
Q1 2022$244,000
-30.9%
24,821
+7.5%
0.00%
Q4 2021$353,00023,0880.00%
Other shareholders
TALARIS THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 2,932,606$28,857,00027.11%
Aisling Capital Management LP 682,923$6,720,0003.63%
Cormorant Asset Management, LP 1,174,723$11,559,0000.89%
Artal Group S.A. 2,064,262$20,312,0000.85%
SECTORAL ASSET MANAGEMENT INC 228,624$2,250,0000.40%
Logos Global Management LP 306,236$3,013,0000.39%
Eventide Asset Management 1,561,092$15,361,0000.24%
Blackstone Inc. 8,089,315$79,599,0000.20%
HHLR ADVISORS, LTD. 698,797$6,876,0000.14%
VIKING GLOBAL INVESTORS LP 3,289,617$32,370,0000.13%
View complete list of TALARIS THERAPEUTICS INC shareholders